Congress Demands Answers on Data Privacy Ahead of 23andMe Sale

As news of the potential sale of 23andMe, a popular genetic testing company, circulates, Congress has begun to demand answers on data privacy concerns.

Members of Congress have expressed worries about the implications of sensitive genetic information falling into the wrong hands.

23andMe has long touted its commitment to protecting customer data, but recent controversies and data breaches have raised doubts among lawmakers.

Congressional hearings are being planned to address these concerns and hold 23andMe accountable for ensuring the privacy and security of its users’ information.

This push for transparency and accountability comes amidst a growing awareness of the importance of data privacy in the digital age.

The sale of 23andMe could have far-reaching consequences for individuals who have entrusted their genetic data to the company.

Lawmakers are calling on 23andMe to provide assurances that the privacy of users will be safeguarded in any potential deal.

As the debate over data privacy heats up, the outcome of these congressional inquiries could have a profound impact on the future of genetic testing and data protection.

Consumers are urged to stay informed and advocate for their right to privacy in the digital age.